Prasad Resigns From Top FDA Post Amid Fallout Over Sarepta Dispute
As director of the Center for Biologics Evaluation and Research, Dr. Vinay Prasad oversaw the regulation of vaccines and gene therapy drugs such as Sarepta Therapeutics' treatment for Duchenne muscular dystrophy. During his brief tenure, Prasad limited the use of covid shots and amped up warnings about a rare cardiac side effect of the shots, The New York Times wrote.